| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |